Academic Journal
Q1European Heart Journal – Cardiovascular Pharmacotherapy
About European Heart Journal – Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy is a scholarly journal published by Oxford University Press. SCImago 2025 lists it in Q1, with an SJR of 2.014 and H-index of 50.
Coverage: 2015-2026. Research categories: Cardiology and Cardiovascular Medicine (Q1); Pharmacology (medical) (Q1).
Source-backed journal facts
Topics in published research
Atrial Fibrillation Management and Outcomes; Antiplatelet Therapy and Cardiovascular Diseases; Acute Myocardial Infarction Research; Heart Failure Treatment and Management; Lipoproteins and Cardiovascular Health; Diabetes Treatment and Management.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,983.00 EUR
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Statins for primary prevention in the elderly
Jessica Schubert, Margret Leosdottir
2026-09-30 · DOI: 10.1093/ehjcvp/pvag082Average daily ischemic and bleeding risk following acute coronary syndrome: Insights from the FORCE-ACS registry
Jaouad Azzahhafi, Dean R P P Chan Pin Yin, Niels M R van der Sangen, Wout W A van den Broek et al.
2026-09-30 · DOI: 10.1093/ehjcvp/pvag084Clopidogrel in-laboratory versus outpatient preloading in chronic coronary syndrome patients undergoing diagnostic coronary angiography with potential ad-hoc percutaneous coronary intervention
Rosanne F Vogel, Elsbeth C Noppers, Niels J Verouden, Jose P S Henriques et al.
2026-09-29 · DOI: 10.1093/ehjcvp/pvag083Rewriting heart health: epigenetic drugs in cardiovascular medicine
Natalia Atzemian, Ludovica Di Venanzio, Shafeeq Ahmed Mohammed, Sarah Costantino et al.
2026-09-24 · DOI: 10.1093/ehjcvp/pvag075Coated or chewable aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: rationale and design of the COATED-AIR randomized trial
Behnood Bikdeli, Azita H Talasaz, Hooman Bakhshandeh, Mohammad Sadegh Hassanvand et al.
2026-09-23 · DOI: 10.1093/ehjcvp/pvag071From digital reminders to AI-enabled understanding: can personalized treatment predictions improve therapeutic adherence?
Valentin Goutaudier, Jean-Sébastien Hulot
2026-09-22 · DOI: 10.1093/ehjcvp/pvag079Can ARNI Prevent Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction? Real-World Evidence Meets the Randomized Benchmark
Enrico Volpe, Stanislovas Jankauskas, Pasquale Mone, Shivangi Pande et al.
2026-09-22 · DOI: 10.1093/ehjcvp/pvag080Ischemic Limb Necrosis and Symmetrical Peripheral Gangrene During Vasopressor Support in Severe Shock States: Thromboinflammatory Microvascular Injury as the Pathogenic Mechanism
Jerrold H Levy, Joseph R Shaw, Jean M Connors, Dominik F Draxler et al.
2026-09-19 · DOI: 10.1093/ehjcvp/pvag078Response to letter translating cardio-rheumatology into practice: a multi-level pilot network
Anne Grete Semb, Eirik Ikdahl, Anne Kerola
2026-09-16 · DOI: 10.1093/ehjcvp/pvag061Antiemetic-Associated QT Prolongation: A Clinical Review and Risk-Stratified Prescribing Framework for Long QT Syndrome
Ahmed T Moustafa, Omar Dabash, Pradosh Kumar Panigrahi, Habib Rehman Khan et al.
2026-09-16 · DOI: 10.1093/ehjcvp/pvag077Switching to angiotensin receptor–neprilysin inhibitor and reduced risk of new-onset atrial fibrillation in heart failure with reduced ejection fraction: a nationwide propensity score–matched study
Young Jun Park, Dong-Hyuk Cho, Jimi Choi, Jong-Chan Youn et al.
2026-09-15 · DOI: 10.1093/ehjcvp/pvag074Real-world analysis of adherence, persistence, and outcomes in patients receiving four-drug antihypertensive therapy
Giuseppe Mancia, Sofie Brouwers, Silvia Calabria, Melania Leogrande et al.
2026-09-15 · DOI: 10.1093/ehjcvp/pvag073Sacubitril/valsartan and cardiac injury/stress and systemic inflammatory biomarkers in acute heart failure: a pre-specified secondary analysis of the PREMIER study
Shunichi Doi, Atsushi Tanaka, Takumi Imai, Goro Yoshioka et al.
2026-09-11 · DOI: 10.1093/ehjcvp/pvag076Translating cardiorheumatology into practice: a multilevel pilot network
Gian Luca Erre, Fabio Cacciapaglia, Giuseppe Damiano Sanna, Fabiola Atzeni et al.
2026-09-11 · DOI: 10.1093/ehjcvp/pvag070Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohort
Karl Wärnberg, Carl Haggård, Karin Bergen, Henrik Falhammar et al.
2026-09-10 · DOI: 10.1093/ehjcvp/pvag064Vagal activity-related events and glucagon-like peptide-1 receptor agonists
Lina Al-Ansary, Sebastian Kinnberg Nielsen, Mads Hashiba Jensen, Nina Nouhravesh et al.
2026-09-08 · DOI: 10.1093/ehjcvp/pvag072Response to Lu Li and colleagues
Angelo Avogaro, Mauro Gori, Giuseppe Grandaliano, Massimo Iacoviello et al.
2026-09-22 · DOI: 10.1093/ehjcvp/pvag062Universal evidence and contextual pharmacotherapy
Bianca Rocca
2026-09-22 · DOI: 10.1093/ehjcvp/pvag065Rethinking the CVOT design in an era of high-performing background therapy
Nicola Cosentino, Gianluca Pontone
2026-08-29 · DOI: 10.1093/ehjcvp/pvag069Comparative biomarker efficacy of cholesteryl ester transfer protein inhibitors: a network meta-analysis
Maciej Banach, Vikash Jaiswal, Song Peng Ang, Hanna Ahuja et al.
2026-08-28 · DOI: 10.1093/ehjcvp/pvag067Reviews
Community Reviews
Version History
October 4, 2026 at 8:47 pm
September 25, 2026